Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease

• Ph. Gabriel Steg ,

  * E-mail: gabriel.steg@bch.ap-hop-paris.fr

  Affiliations INSERM U698, Paris, France, Université Paris Diderot, Paris, France, AP-HP, Hôpital Bichat, Paris, France

  ⨯
• Roberto Ferrari,

  Affiliation Department of Cardiology and LTTA Centre, University of Ferrara, Salvatore Maugeri Foundation, IRCCS, Lumezzan, Italy

  ⨯
• Ian Ford,

  Affiliation University of Glasgow, Glasgow, United Kingdom

  ⨯
• Nicola Greenlaw,

  Affiliation University of Glasgow, Glasgow, United Kingdom

  ⨯
• Jean-Claude Tardif,

  Affiliation Montreal Heart Institute, Université de Montreal, Montreal, Canada

  ⨯
• Michal Tendera,

  Affiliation Medical University of Silesia, Katowice, Poland

  ⨯
• Hélène Abergel,

  Affiliations INSERM U698, Paris, France, Université Paris Diderot, Paris, France, AP-HP, Hôpital Bichat, Paris, France

  ⨯
• Kim M. Fox,

  Affiliation NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom

  ⨯
• for the CLARIFY Investigators

  ¶For a full list of the CLARIFY investigators please see Appendix S1.

  ⨯